Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines

Journal of Bone and Joint Surgery

Volumn 78, Issue 3, 1996, Pages 366-375

  Takeshita, Hideyuki ^a,b   Gebhardt, Mark C ^a,c   Springfield, Dempsey S ^a,c   Kusuzaki, Katsuyuki ^a,d   Mankin, Henry J ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Kohoku General Hospital   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GLYCOPROTEIN P; IFOSFAMIDE; METHOTREXATE; MITOMYCIN C; TRIFLUOPERAZINE; VERAPAMIL; VINBLASTINE; VINCRISTINE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CROSS RESISTANCE; DRUG TRANSPORT; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; OSTEOSARCOMA CELL; PHENOTYPE; PRIORITY JOURNAL;

EID: 0029876254     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-199603000-00007     Document Type: Article

References (41)

1. Bartlett, N. L.; Lum, B. L.; Fisher, G. A.; Brophy, N. A.; Ehsan, M. N.; Halsey, J.; and Sikic, B. I.: Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance. J. Clin. Oncol., 12: 835-842, 1994.
2. Bell, R. S.; Roth, Y. F.; Gebhardt, M. C.; Bell, D. F.; Rosenberg, A. E.; Mankin, H. J.; and Suit, H. D.: Timing of chemotherapy and surgery in a murine osteosarcoma model. Cancer Res., 48: 5533-5538, 1988.
3. Biedler, J. L.; Casals, D.; Chang, T.-D.; Meyers, M. B.; Spengler, B. A.; and Ross, R. A.: Multidrug-resistant human neuroblastoma cells are more differentiated than controls and retinoic acid further induces lineage-specific differentiation. In Advances in Neuroblastoma Research 3: Proceedings of the Fifth Symposium on Advances in Neuroblastoma Research, Held in Philadelphia, Pennsylvania, May 28-30, 1990, pp. 181-191. Edited by A. E. Evans, G. J. D'Angio, A. G. Knudson, Jr., and R. C. Seeger. New York, Wiley-Liss, 1991.
4. Boesch, D.; Muller, K.; Pourtier-Manzanedo, A.; and Loor, F.: Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative. Exper. Cell Res., 196: 26-32, 1991.
5. Bourhis, J.; Benard, J.; Hartmann, O.; Boccon-Gibod, L.; Lemerle, J.; and Riou, G.: Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J. Nat. Cancer Inst., 81: 1401-1405, 1989.
6. Chan, H. S.; Thorner, P. S.; Haddad, G.; and Ling, V.: Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J. Clin. Oncol , 8: 689-704, 1990.
7. Chan, H. S.; Thorner, P. S.; Haddad, G.; DeBoer, G.; and Ling, V.: Multidrug resistance in sarcomas of children. In Frontiers of Osteosarcoma Research Interdisciplinary Survey of Clinical and Research Advances, pp 51-63. Edited by J F. Novak and J. H. McMaster. Seattle, Hogrefe and Huber, 1993.
8. Chan, H. S.; Haddad, G.; Thorner, P. S.; DeBoer, G.; Lin, Y. P.; Ondrusek, N.; Yeger, H.; and Ling, V.: P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. New England J. Med., 325: 1608-1614, 1991.
9. Charles, S. M., and Kenneth, H. C.: Glutathione S-transferase and drug resistance. Cancer Cells, 2: 15-22, 1990.
10. Chen, C. J.; Chin, J. E.; Ueda, K.; Clark, D. P.; Pastan, I.; Gottesman, M. M.; and Roninson, I. B.: Internal duplication and homology with bacterial transport proteins in the MDR1 (P-glycoprotein) gene from multidrug resistant human cells. Cell, 47: 381-389, 1986.
11. Choi, C. H.; Sedlacek, R. S.; and Suit, H. D.: Radiation-induced osteogenic sarcoma of C3H mouse: effects of corynebacterium parvum and WBI on its natural history and response to irradiation. European J. Cancer, 15: 433-442, 1979.
12. Cole, S. P.; Downes, H. F.; Mirski, S. E.; and Clements, D. J.: Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line. Molec. Pharmacol , 37: 192-197, 1990.
13. Cole, S. P.; Chanda, E. R.; Dicke, F. P.; Gerlach, J. H.; and Mirski, S. E.: Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II. Cancer Res., 51: 3345-3352, 1991.
14. Cordon-Cardo, C.; O'Brien, J. P.; Casals, D.; Rittman-Grauer, L.; Biedler, J. L.; Melamed, M. R.; and Bertino, J.: Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Nat. Acad. Sci., 86: 695-698, 1989.
15. Dalton, W. S.; Grogan, T. M.; Meltzer, P. S.; Scheper, R. J.; Durie, B. G.; Taylor, C. W.; Miller, T. P.; and Salmon, S. E.: Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J. Clin. Oncol., 7: 415-424, 1989.
16. De Jong, S.; Zijlstra, J. G.; de Vries, E. G.; and Mulder, N. H.: Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an Adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res., 50: 304-309, 1990.
17. Eastman, A., and Schulte, N.: Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum (II). Biochemistry, 27: 4730-4734, 1988.
18. Fairchild, C. R.; Ivy, S. P.; Kao-Shan, C.-S.; Whang-Peng, J.; Rosen, N.; Israel, M. A.; Melera, P. W.; Cowan, K. H.; and Goldsmith, M. E.: Isolation of amplified and overexpressed DNA sequences from Adriamycin-resistant human breast cancer cells. Cancer Res., 47: 5141-5148, 1987.
19. Fojo, A. T.; Ueda, K.; Slamon, D. J.; Poplack, D. G.; Gottesman, M. M.; and Pastan, I.: Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Nat. Acad. Sci., 84: 265-269, 1987.
20. Friedman, M. A., and Carter, S. K.: The therapy of osteogenic sarcoma: current status and thoughts for the future. J. Surg. Oncol , 4: 482-510, 1972.
21. Gerlach, J. H.; Kartner, N.; Bell, D. R.; and Ling, V.: Multidrug resistance. Cancer Survey, 5: 25-46, 1986.
22. Gerlach, J. H.; Endicott, J. A.; Juranka, P. F.; Henderson, G.; Sarangi, F.; Deuchars, K. L.; and Ling, V.: Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature, 324: 485-489, 1986.
23. Giavazzi, R.; Kartner, N.; and Hart, I. R.: Expression of cell surface P-glycoprotein by an Adriamycin-resistant murine fibrosarcoma. Cancer Chemother. and Pharmacol., 13: 145-147, 1984.
24. Hansen, M. B.; Nielsen, S. E.; and Berg, K.: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Meth., 119: 203-210, 1989.
25. Kartner, N.; Riordan, J. R.; and Ling, V.: Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science, 221: 1285-1288, 1983.
26. Keizer, H. G.; Schuurhuis, G. J.; Broxterman, H. J.; Lankelma, J.; Schoonen, W. G.; van Rijn, J.; Pinedo, H. M.; and Joenje, H.: Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells. Cancer Res., 49: 2988-2993, 1989
27. Kelly, S. L.; Basu, A.; Teicher, B. A.; Hacker, M. P.; Hamer, D. H.; and Lazo, J. S.: Overexpression of metallothionein confers resistance to anticancer drugs. Science, 241: 1813-1815, 1988.
28. LaQuaglia, M. P.; Kopp, E. B.; Spengler, B. A.; Meyers, M. B.; and Biedler, J. L.: Multidrug resistance in human neuroblastoma cells. J. Pediat. Surg., 26: 1107-1112, 1991.
29. Link, M. P.: Preoperative and adjuvant chemotherapy in osteosarcoma. In Frontiers of Osteosarcoma Research: Interdisciplinary Survey of Clinical and Research Advances, pp 41-49. Edited by J. F. Novak and J. H. McMaster. Seattle, Hogrefe and Huber, 1993.
30. Lowry, O. H.: Micromethods for the assay of enzymes. II. Specific procedures. Alkaline phosphatase. Meth. Enzymol., 4: 371-372, 1957.
31. Miller, R. L.; Bukowski, R. M.; Budd, G. T.; Purvis, J.; Weick, J. K.; Shepard, K.; Midha, K. K.; and Ganapathi, R.: Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial. J. Clin. Oncol., 6: 880-888, 1988.
32. Miller, T. P.; Grogan, T. M.; Dalton, W. S.; Spier, C. M.; Scheper, R. J.; and Salmon, S. E.: P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. J. Clin. Oncol , 9: 17-24, 1991.
33. Nigg, E. A.; Baeuerle, P. A.; and Luhrmann, R.: Nuclear import-export: in search of signals and mechanisms. Cell, 66: 15-22, 1991.
34. Ozols, R. F.; Cunnion, R. E.; Klecker, R. W., Jr.; Hamilton, T. C.; Ostchega, Y.; Parrillo, J. E.; and Young, R. C.: Verapamil and Adriamycin in the treatment of drug-resistant ovarian cancer patients. J. Clin. Oncol . 5: 641-647, 1987.
35. Pastan, I., and Gottesman, M.: Multiple-drug resistance in human cancer. New England J. Med., 316: 1388-1393, 1987.
36. Pennock, G. D.; Dalton, W. S.; Roeske, W. R.; Appleton, C. P.; Mosley, K.; Plezia, P.; Miller, T. P.; and Salmon, S.: Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration. J. Nat Cancer Inst., 83: 105-110, 1991.
37. Sato, W.; Fukazawa, N.; Suzuki, T.; Yusa, K.; and Tsuruo, T.: Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073. Cancer Res., 51: 2420-2424, 1991.
38. Shinoda, H.; Inaba, M.; and Tsuruo, T.: In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52 Cancer Res., 49: 1722-1726, 1989.
39. Sugawara, I.; Kataoka, I.; Morishita, Y.; Hamada, H.; Tsuruo, T.; Itoyama, S.; and Mori, S.: Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res., 48: 1926-1929, 1988.
40. Tatsuta, T.; Naito, M.; Oh-hara, T.; Sugawara, I.; and Tsuruo, T.: Functional involvement of P-glycoprotein in blood-brain barrier. Biol. Chem., 267: 20383-20391, 1992.
41. Timmer-Bosscha, H.; Hospers, G. A.; Meijer, C.; Mulder, N. H.; Muskiet, F. A.; Martini, I. A.; Uges, D. R.; and de Vries, E. G.: Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line. J. Nat. Cancer Inst., 81: 1069-1075, 1989.